Close
Back to ALNY Stock Lookup
Pages: 1 2 »» Last Page

Alnylam Pharma (ALNY) – Major News

Feb 15, 2024 08:05 AM Alnylam Pharma (ALNY) Tops Q4 EPS by 49c; offers guidance
Nov 2, 2023 08:06 AM Alnylam Pharma (ALNY) Tops Q3 EPS by $3.06
Aug 3, 2023 08:01 AM Alnylam Pharma (ALNY) Misses Q2 EPS by 10c
May 4, 2023 08:06 AM Alnylam Pharma (ALNY) Tops Q1 EPS by 62c, Beats on Revenue; Offers FY23 Guidance
Feb 23, 2023 08:04 AM Alnylam Pharma (ALNY) Tops Q4 EPS by 46c
Oct 27, 2022 08:03 AM Alnylam Pharma (ALNY) Tops Q3 EPS by 15c, Misses on Revenue, Offers FY22 Revenue Guidance
Aug 3, 2022 07:01 AM Alnylam Pharma (ALNY) Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy Met Primary Endpoint
Jul 28, 2022 08:05 AM Alnylam Pharma (ALNY) Misses Q2 EPS by 42c
Apr 28, 2022 08:08 AM Alnylam Pharma (ALNY) Tops Q1 EPS by 35c
Feb 10, 2022 08:07 AM Alnylam Pharma (ALNY) Misses Q4 EPS by 13c
Oct 28, 2021 08:13 AM Alnylam Pharma (ALNY) Misses Q3 EPS by 15c
Aug 3, 2021 08:03 AM Alnylam Pharma (ALNY) Tops Q2 EPS by 30c
Apr 29, 2021 08:15 AM Alnylam Pharma (ALNY) Tops Q1 EPS by 11c
Feb 11, 2021 08:03 AM Alnylam Pharma (ALNY) Tops Q4 EPS by 16c
Nov 5, 2020 08:17 AM Alnylam Pharma (ALNY) Tops Q3 EPS by 8c
Aug 6, 2020 08:03 AM Alnylam Pharma (ALNY) Tops Q2 EPS by 7c
May 6, 2020 08:01 AM Alnylam Pharma (ALNY) Tops Q1 EPS by 37c
Feb 6, 2020 08:08 AM Alnylam Pharma (ALNY) Tops Q4 EPS by 24c
Oct 31, 2019 08:01 AM Alnylam Pharma (ALNY) Tops Q3 EPS by 54c
Aug 6, 2019 07:52 AM Alnylam Pharma (ALNY) Misses Q2 EPS by 16c
May 1, 2019 08:06 AM Alnylam Pharma (ALNY) Tops Q1 EPS by 65c
Apr 8, 2019 07:02 AM Alnylam (ALNY), Regeneron (REGN) Announce Pact on RNAi Therapeutics Focused on Ocular and CNS Diseases; Regeneron to Make Payment of $400M Upfront and Purchase Stock at $90/Share
Mar 6, 2019 07:01 AM Alnylam Pharma (ALNY) ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria Met Primary Efficacy Endpoint
Feb 7, 2019 04:14 PM Alnylam Pharma (ALNY) Tops Q4 EPS by 19c
Nov 7, 2018 08:06 AM Alnylam Pharma (ALNY) Misses Q3 EPS by 42c
Aug 10, 2018 01:00 PM Alnylam Pharma (ALNY) Patisiran (Onpattro) Approved by FDA
Aug 2, 2018 08:05 AM Alnylam Pharma (ALNY) Tops Q2 EPS by 16c
May 3, 2018 04:01 PM Alnylam Pharma (ALNY) Posts Smaller-than-Expected Q1 Loss
Feb 8, 2018 08:09 AM Alnylam Pharma (ALNY) Tops Q4 EPS by 19c, Beats on Revenues
Nov 20, 2017 07:01 AM Alnylam Pharma (ALNY) Granted FDA Breakthrough Therapy Designation for Patisiran
Nov 7, 2017 04:01 PM Alnylam Pharma (ALNY) Tops Q3 EPS by 21c
Sep 20, 2017 07:02 AM Sanofi, Alnylam Pharmaceuticals (ALNY) Announces APOLLO Phase 3 Study of Patisiran Met Primary Efficacy Endpoint and All Secondary Endpoints
Aug 9, 2017 04:01 PM Alnylam Pharma (ALNY) Tops Q2 EPS by 15c
May 5, 2017 08:01 AM Alnylam Pharma (ALNY) Tops Q1 EPS by 1c
Feb 8, 2017 04:07 PM Alnylam Pharma (ALNY) Tops Q4 EPS by 2c
Nov 2, 2016 04:13 PM Alnylam Pharma (ALNY) Misses Q3 EPS by 7c
Nov 2, 2016 04:02 PM Alnylam Pharma (ALNY) Misses Q3 EPS by 7c
Oct 5, 2016 04:31 PM Alnylam Pharma (ALNY) to Discontinue Development of Revusiran; Decision Will Not Affect Patisiran
Aug 4, 2016 04:01 PM Alnylam Pharma (ALNY) Tops Q2 EPS by 19c
May 2, 2016 04:03 PM Alnylam Pharma (ALNY) Misses Q1 EPS by 16c
Feb 11, 2016 04:15 PM Alnylam Pharma (ALNY) Misses Q4 EPS by 11c
Nov 9, 2015 07:13 AM Alnylam Pharma (ALNY) Reports In-Line Q3 EPS
Aug 6, 2015 04:03 PM Alnylam Pharma (ALNY) Misses Q2 EPS by 10c
May 7, 2015 04:01 PM Alnylam Pharma (ALNY) Tops Q1 EPS by 4c
Feb 12, 2015 04:00 PM Alnylam Pharma (ALNY) Tops Q4 EPS by 32c
Nov 5, 2014 04:50 PM Alnylam Pharma (ALNY) Tops Q3 EPS by 5c
Aug 7, 2014 04:32 PM Alnylam Pharmaceuticals, Inc. (ALNY) Misses Q2 EPS by 7c
May 8, 2014 04:25 PM Alnylam Pharmaceuticals, Inc. (ALNY) Posts Q1 Loss of 39c/Share
Feb 13, 2014 04:19 PM Alnylam Pharmaceuticals, Inc. (ALNY) Misses Q4 EPS by 6c
Jan 13, 2014 09:24 AM Alnylam Pharmaceuticals (ALNY) Surges on Deal to Acquire Merck's (MRK) Sirna Therapeutics for $175M+
Pages: 1 2 »» Last Page

Back to ALNY Stock Lookup